Current Report Filing (8-k)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuantto Section13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): February2, 2017
CATALYST BIOSCIENCES, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 000-51173 | 56-2020050 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||
| 260 Littlefield Ave., South San Francisco, California | 94080 | |||
| (Address of principal executive offices) | (Zip Code) | |||
Registrants telephone number, including area code: (650)266-8674
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of thefollowing provisions (see General Instruction A.2. below):
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item5.07 | Submission of Matters to a Vote of Security Holders. |
At a special meeting of stockholders (theSpecial Meeting) of Catalyst Biosciences, Inc. (the Company), held on February2, 2017, the Company received the certified final voting results, which included zero broker non-votes, from the inspector of elections, aspresented below:
| FOR | AGAINST | ABSTAIN | ||||||||||
1.Approve the authorization of the Board of Directors of theCompany, in its discretion at any time prior to June 30, 2017, to file an amendment to the Companys Fourth Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of the Companys outstanding commonstock at a ratio of at least one-for-five and up to one-for-fifteen. | 9,487,585 | 367,241 | 69,086 | |||||||||
The Companys stockholders neither considered nor voted on any other matters.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersignedhereunto duly authorized.
| Catalyst Biosciences, Inc. | ||||||
| Dated: February2, 2017 | By: | /s/ Fletcher Payne | ||||
Fletcher Payne | ||||||
| Chief Financial Officer | ||||||
Catalyst Biosciences (NASDAQ:CBIO)
Historical Stock Chart
From Jul 2024 to Aug 2024
Catalyst Biosciences (NASDAQ:CBIO)
Historical Stock Chart
From Aug 2023 to Aug 2024
 | {{bbMessage.M_Alias}}{{bbMessage.MSG_Date}}{{bbMessage.HowLongAgo}}{{bbMessage.MSG_ID}}{{bbMessage.MSG_Subject}} |
Loading Messages....
Catalyst Biosciences, Inc. News
Loading Messages....
`,data() {return {tabs: [] };},created() {this.tabs = this.$children;},methods: {selectTab(selectedTab) {this.tabs.forEach(tab => {tab.isActive = (tab.name == selectedTab.name);});}}});Vue.component('tab', {template: `
`,props: {name: { required: true },selected: { default: false}},data() {return {isActive: false};},computed: {href() {return '#' + this.name.toLowerCase().replace(/ /g, '-');}},mounted() {this.isActive = this.selected;}});Vue.component('newslist', {template: `
FEATURED
•{{ article.source }} • {{ article.date}} {{article.time}}
`,props: {source: { required: true },rawarticles: { required: true },limit: { default: 12 }},methods: {processData: function(articles){if(articles.length > this.limit){articles = articles.slice(0, this.limit);}this.articles = articles;this.loaded = true;Vue.nextTick(function(){});},stripRedudancies: function(articles){return _.uniqBy(articles, "headline");}},data() {return {loaded: false,articles: []};},mounted() {this.processData(this.rawarticles);}});new Vue({el: '#nw-news-widget',data: {loaded: false,availableTabs: {"Press Releases": [{"headline":"Mawson Finland Provides Update on Exploration Activities at Rajapalot","link":"https:\/\/ih.advfn.com\/common\/newswire\/ct\/MjIxNg==","timestamp":1724241992,"date":"Wed Aug 21, 2024 ","time":"8:06 AM (18 hours ago)","isPromoted":true},{"headline":"Form 4 - Statement of changes in beneficial ownership of securities","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/catalyst-biosciences-CBIO\/stock-news\/94402035\/form-4-statement-of-changes-in-beneficial-owners","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1723857209,"date":"Fri Aug 16, 2024 ","time":"9:13 PM (5 days ago)","full_date":"August 16, 2024 9:13 PM","post_time":"August 16 2024","article_id":94402035,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 4 - Statement of changes in beneficial ownership of securities","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/catalyst-biosciences-CBIO\/stock-news\/94402362\/form-4-statement-of-changes-in-beneficial-owners","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1723857028,"date":"Fri Aug 16, 2024 ","time":"9:10 PM (5 days ago)","full_date":"August 16, 2024 9:10 PM","post_time":"August 16 2024","article_id":94402362,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 4 - Statement of changes in beneficial ownership of securities","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/catalyst-biosciences-CBIO\/stock-news\/94402026\/form-4-statement-of-changes-in-beneficial-owners","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1723856871,"date":"Fri Aug 16, 2024 ","time":"9:07 PM (5 days ago)","full_date":"August 16, 2024 9:07 PM","post_time":"August 16 2024","article_id":94402026,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 4 - Statement of changes in beneficial ownership of securities","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/catalyst-biosciences-CBIO\/stock-news\/94402024\/form-4-statement-of-changes-in-beneficial-owners","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1723856718,"date":"Fri Aug 16, 2024 ","time":"9:05 PM (5 days ago)","full_date":"August 16, 2024 9:05 PM","post_time":"August 16 2024","article_id":94402024,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 4 - Statement of changes in beneficial ownership of securities","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/catalyst-biosciences-CBIO\/stock-news\/94402021\/form-4-statement-of-changes-in-beneficial-owners","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1723856494,"date":"Fri Aug 16, 2024 ","time":"9:01 PM (5 days ago)","full_date":"August 16, 2024 9:01 PM","post_time":"August 16 2024","article_id":94402021,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 4 - Statement of changes in beneficial ownership of securities","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/catalyst-biosciences-CBIO\/stock-news\/94402017\/form-4-statement-of-changes-in-beneficial-owners","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1723856319,"date":"Fri Aug 16, 2024 ","time":"8:58 PM (5 days ago)","full_date":"August 16, 2024 8:58 PM","post_time":"August 16 2024","article_id":94402017,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 4 - Statement of changes in beneficial ownership of securities","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/catalyst-biosciences-CBIO\/stock-news\/94402014\/form-4-statement-of-changes-in-beneficial-owners","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1723856161,"date":"Fri Aug 16, 2024 ","time":"8:56 PM (5 days ago)","full_date":"August 16, 2024 8:56 PM","post_time":"August 16 2024","article_id":94402014,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 4 - Statement of changes in beneficial ownership of securities","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/catalyst-biosciences-CBIO\/stock-news\/94402011\/form-4-statement-of-changes-in-beneficial-owners","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1723855998,"date":"Fri Aug 16, 2024 ","time":"8:53 PM (5 days ago)","full_date":"August 16, 2024 8:53 PM","post_time":"August 16 2024","article_id":94402011,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 4 - Statement of changes in beneficial ownership of securities","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/catalyst-biosciences-CBIO\/stock-news\/94402010\/form-4-statement-of-changes-in-beneficial-owners","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1723855824,"date":"Fri Aug 16, 2024 ","time":"8:50 PM (5 days ago)","full_date":"August 16, 2024 8:50 PM","post_time":"August 16 2024","article_id":94402010,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/catalyst-biosciences-CBIO\/stock-news\/94373026\/form-10-q-quarterly-report-sections-13-or-15d","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1723579532,"date":"Tue Aug 13, 2024 ","time":"4:05 PM (1 week ago)","full_date":"August 13, 2024 4:05 PM","post_time":"August 13 2024","article_id":94373026,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 3 - Initial statement of beneficial ownership of securities","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/catalyst-biosciences-CBIO\/stock-news\/94347047\/form-3-initial-statement-of-beneficial-ownership","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1723148600,"date":"Thu Aug 08, 2024 ","time":"4:23 PM (2 weeks ago)","full_date":"August 8, 2024 4:23 PM","post_time":"August 08 2024","article_id":94347047,"source_id":"edgar2","media_url":null,"press_release":true}],"All News": [{"headline":"Mawson Finland Provides Update on Exploration Activities at Rajapalot","link":"https:\/\/ih.advfn.com\/common\/newswire\/ct\/MjIxNg==","timestamp":1724241992,"date":"Wed Aug 21, 2024 ","time":"8:06 AM (18 hours ago)","isPromoted":true},{"headline":"Form 4 - Statement of changes in beneficial ownership of securities","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/catalyst-biosciences-CBIO\/stock-news\/94402035\/form-4-statement-of-changes-in-beneficial-owners","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1723857209,"date":"Fri Aug 16, 2024 ","time":"9:13 PM (5 days ago)","full_date":"August 16, 2024 9:13 PM","post_time":"August 16 2024","article_id":94402035,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 4 - Statement of changes in beneficial ownership of securities","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/catalyst-biosciences-CBIO\/stock-news\/94402362\/form-4-statement-of-changes-in-beneficial-owners","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1723857028,"date":"Fri Aug 16, 2024 ","time":"9:10 PM (5 days ago)","full_date":"August 16, 2024 9:10 PM","post_time":"August 16 2024","article_id":94402362,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 4 - Statement of changes in beneficial ownership of securities","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/catalyst-biosciences-CBIO\/stock-news\/94402026\/form-4-statement-of-changes-in-beneficial-owners","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1723856871,"date":"Fri Aug 16, 2024 ","time":"9:07 PM (5 days ago)","full_date":"August 16, 2024 9:07 PM","post_time":"August 16 2024","article_id":94402026,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 4 - Statement of changes in beneficial ownership of securities","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/catalyst-biosciences-CBIO\/stock-news\/94402024\/form-4-statement-of-changes-in-beneficial-owners","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1723856718,"date":"Fri Aug 16, 2024 ","time":"9:05 PM (5 days ago)","full_date":"August 16, 2024 9:05 PM","post_time":"August 16 2024","article_id":94402024,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 4 - Statement of changes in beneficial ownership of securities","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/catalyst-biosciences-CBIO\/stock-news\/94402021\/form-4-statement-of-changes-in-beneficial-owners","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1723856494,"date":"Fri Aug 16, 2024 ","time":"9:01 PM (5 days ago)","full_date":"August 16, 2024 9:01 PM","post_time":"August 16 2024","article_id":94402021,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 4 - Statement of changes in beneficial ownership of securities","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/catalyst-biosciences-CBIO\/stock-news\/94402017\/form-4-statement-of-changes-in-beneficial-owners","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1723856319,"date":"Fri Aug 16, 2024 ","time":"8:58 PM (5 days ago)","full_date":"August 16, 2024 8:58 PM","post_time":"August 16 2024","article_id":94402017,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 4 - Statement of changes in beneficial ownership of securities","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/catalyst-biosciences-CBIO\/stock-news\/94402014\/form-4-statement-of-changes-in-beneficial-owners","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1723856161,"date":"Fri Aug 16, 2024 ","time":"8:56 PM (5 days ago)","full_date":"August 16, 2024 8:56 PM","post_time":"August 16 2024","article_id":94402014,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 4 - Statement of changes in beneficial ownership of securities","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/catalyst-biosciences-CBIO\/stock-news\/94402011\/form-4-statement-of-changes-in-beneficial-owners","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1723855998,"date":"Fri Aug 16, 2024 ","time":"8:53 PM (5 days ago)","full_date":"August 16, 2024 8:53 PM","post_time":"August 16 2024","article_id":94402011,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 4 - Statement of changes in beneficial ownership of securities","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/catalyst-biosciences-CBIO\/stock-news\/94402010\/form-4-statement-of-changes-in-beneficial-owners","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1723855824,"date":"Fri Aug 16, 2024 ","time":"8:50 PM (5 days ago)","full_date":"August 16, 2024 8:50 PM","post_time":"August 16 2024","article_id":94402010,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/catalyst-biosciences-CBIO\/stock-news\/94373026\/form-10-q-quarterly-report-sections-13-or-15d","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1723579532,"date":"Tue Aug 13, 2024 ","time":"4:05 PM (1 week ago)","full_date":"August 13, 2024 4:05 PM","post_time":"August 13 2024","article_id":94373026,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 3 - Initial statement of beneficial ownership of securities","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NASDAQ\/catalyst-biosciences-CBIO\/stock-news\/94347047\/form-3-initial-statement-of-beneficial-ownership","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1723148600,"date":"Thu Aug 08, 2024 ","time":"4:23 PM (2 weeks ago)","full_date":"August 8, 2024 4:23 PM","post_time":"August 08 2024","article_id":94347047,"source_id":"edgar2","media_url":null,"press_release":true}],"Preferred Contributors": ""}},created: function () {this.loaded = true;Vue.nextTick(function(){});}});});
More Catalyst Biosciences, Inc. News Articles
